China Medical System Holdings Limited is a well-established, innovation-driven specialty pharma with a focus on sales and marketing in China, dedicated to offering competitive products and services to meet China's unmet needs for health and beauty. Since 28 September 2010, the Group has been listed on the Main Board of the Stock Exchange of Hong Kong Limited (stock code: 867), and included in the Morgan Stanley Capital International (MSCI) China Index, Hang Seng Healthcare Index, etc. The Group is the object of transaction in both Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect, and also the largest shareholder of Tibet Rhodiola Pharmaceutical Holding Co. (stock code: 600211), a company listed on Shanghai Stock Exchange (A-share).
In 2021, China Medical System Holdings Limited expanded its operations by establishing three subsidiary companies in Singapore: CMS Healthcare Pte Ltd, CMS Biotech Pte Ltd, and CMS Pharma Pte Ltd. To better resonate with the market and enhance our brand identity, we rebranded these subsidiaries in June 2022 as Rxilient Health Pte Ltd, Rxilient Biotech Pte Ltd, and Rxilient Medical Pte Ltd, respectively.
We hold a strong and optimistic outlook for the Southeast Asian market, a region distinguished by its rich cultural tapestry, thriving opportunities, and energetic spirit. Located at the nexus of the maritime route connecting East Asia to the Middle East and Mediterranean, Southeast Asia presents a strategic advantage for the expansion of China's biopharmaceutical industry. Our investment in this region signifies a crucial step towards our company's global growth.
Our unwavering dedication to innovation and deep market insights position us as a key player in the healthcare sector's continued development throughout Southeast Asia. We are excited to tap into the region's potential and contribute to a healthier, more prosperous future for all its inhabitants.
VISION
To be a trusted and innovative pharmaceutical company that advances patient well-being.
MISSION
Provide competitive healthcare solutions for unmet needs.
CORE VALUES
Customer Focus
Innovation
Integrity
Pragmatic
Resilience
Win-win
COMPANY POSITIONING
A versatile open platform that unites pharmaceutical innovation, commercialization, and holistic product lifecycle management.
- Assist, manage and maintain documentation and records necessary for FDA and other regulatory submissions.
- Plan meetings and follow up with cross functional teams to ensure timelines are met.
- Keep abreast and maintain record of changes in the global regulatory requirements for stakeholders to strategies solutions to meet such changes.
- Proactively maintain and update regulatory databases in alignment with regulatory requirements.
- Compile and maintain documentation for post-market vigilance in accordance with regulatory requirements.
- Assist Quality Manager on recurring non-compliance (NC) and audit non-conformances and implement effective corrective actions if any.
- Perform any other ad-hoc duties as and when assigned by the Company.
Related Job Searches:
- Company:
Rxilient Medical Pte Ltd - Designation:
RA Specialist - Profession:
Risk / Product / Project Management - Industry:
Healthcare / Fitness / Sports - Location:
Downtown Core